Current Pharmaceutical Biotechnology 2011-08-01

Methodologies and strategies for the bioengineering of lantibiotics.

Jun-ichi Nagao, Mami Nishie, Kenji Sonomot

Index: Curr. Pharm. Biotechnol. 12 , 1221-1230, (2011)

Full Text: HTML

Abstract

Lantibiotics are ribosomally synthesized, post-translationally modified, peptide antibiotics containing unusual amino acids such as dehydrated amino acids and lanthionine. These unusual amino acids impose conformational constraints on the peptide and contribute to the biological activity and high physicochemical stability of lantibiotics. Recent researches on the modification enzymes responsible for dehydration and cyclization have considerably increased our understanding of their molecular characteristics and relaxed specificity. These insights enabled us to exploit these modification enzymes for developing new lantibiotic variants with improved therapeutic potential. Several methodologies have been explored to engineer novel lantibiotics. Here, we outline the current knowledge of modification enzymes. We also describe the methodologies and strategies used to engineer lantibiotics and provide some examples of successful generation of lantibiotics with enhanced activity.


Related Compounds

Related Articles:

Nine post-translational modifications during the biosynthesis of cinnamycin.

2011-08-31

[J. Am. Chem. Soc. 133 , 13753-13760, (2011)]

Substrate recognition and specificity of the NisB protein, the lantibiotic dehydratase involved in nisin biosynthesis.

2011-09-02

[J. Biol. Chem. 286 , 30552-30560, (2011)]

Leader peptide-directed processing of labyrinthopeptin A2 precursor peptide by the modifying enzyme LabKC.

2011-10-04

[Biochemistry 50 , 8362-8373, (2011)]

Autocrine abscisic acid mediates the UV-B-induced inflammatory response in human granulocytes and keratinocytes. Bruzzone S, Basile G, Mannino E, et al.

[J. Cell Physiol. 227(6) , 2502-10, (2011)]

More Articles...